Cogstate Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COGZF research report →
Price Chart
About the company
Cogstate Limited, a neuroscience technology firm established in 1999 and headquartered in Melbourne, Australia, specializes in digital cognitive assessments and electronic solutions for evaluating clinical outcomes. The company offers a comprehensive suite of cognitive services, encompassing project and data management, scientific consulting, statistical interpretation, acquisition of assessment tools, rater training, and monitoring solutions. It operates through two primary divisions: Clinical Trials and Healthcare.
- CEO
- Bradley John O'Connor
- IPO
- 2010
- Employees
- 160
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on COGZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $356.83M
- P/E
- 31.54
- Fwd P/E
- 16.92
- PEG
- 1.99
- P/S
- 6.36
- P/B
- 6.42
- EV/EBITDA
- 22.34
- Div Yield
- 0.65%
- Gross Margin
- 33.72%
- Op Margin
- 20.54%
- Net Margin
- 20.26%
- ROE
- 21.61%
- ROIC
- 14.48%
Latest fiscal year · YoY change
- Revenue
- $59.81M+79.7%
- Gross Profit
- $20.22M+0.6%
- Op Income
- $12.34M
- Net Income
- $12.14M+82.7%
- EPS
- $0.07+86.4%
- OCF Growth
- -15.6%
- FCF Growth
- +9.0%
- 52W High
- $2.12
- 52W Low
- $1.00
- 50D MA
- $1.87
- 200D MA
- $1.69
- Beta
- 0.19
- RSI (14)
- 73
- Avg Volume
- 1.08K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the COGZF Q4 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 46.5%
- Shares Outstanding
- 169.92M
- Float Shares
- 79.01M
Our COGZF coverage
Recent articles, reports, and earnings notes.
No research on COGZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COGZF report →Cogstate Limited (COGZF) Q4 2026 Earnings Call Transcript
seekingalpha.com · Aug 18
Cogstate Limited (COGZF) Discusses Clinical Trials Growth Through Indication and Solution Expansion With Focus on Psychiatry and Narcolepsy Transcript
seekingalpha.com · Jun 10
Cogstate Limited (COGZF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Feb 18
Cogstate Limited (COGZF) FY 2025 Earnings Call Transcript
seekingalpha.com · Aug 22
Cogstate Limited (COGZF) Q2 2025 Earnings Call Transcript
seekingalpha.com · Feb 19
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
globenewswire.com · Oct 14
Cogstate Limited (COGZF) Q4 2024 Earnings Call Transcript
seekingalpha.com · Aug 22
Cogstate Limited (COGZF) Q4 2022 Earnings Call Transcript
seekingalpha.com · Aug 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.